European Park Co-operation


Bilbao / Heidelberg - In mid-March two technology parks in Spain and Germany opened a new dimension of European co-operation by signing a “Memorandum of Understanding”. The Bask government intends to establish Bilbao as a European biotechnology hotspot. Until 2005 nearly Euro180 million are earmarked for the project BioBask. The lion share of the investments is to come from private sources.
Mauri Lazkano, Chairman of the Tech-nology Park Bilbao and President of the Network of Bask Technology Parks explained: “Heidelberg is a prime example in Europe. At Bilbao we would like to establish a similarly successful biotech network.“
According to Klaus Plate, PhD, Managing Director of the Technology Park Hei-delberg, the co-operation with Bilbao represents an important step to set-up new important links with one of the most successful and dynamically growing economic regions in Spain and in Europe.
The Technology Park Bilbao comprises of a total area of 205 hectars. Currently 48,500 m2 are available for rent. A further 182,500 m2 belong to companies presently trading at the park.
The Technology Park Bilbao is the biggest technology centre in Spain, home to 129 companies employing some 5,350 people.
The Technology Park Heidelberg is a science park. The Biopark at its centre is part of the Heidelberg University campus. The park was set up in 1985. Back then with its 11 founding companies and 6,000 m2 laboratory and office space it was Germany's first biopark. Today the park manages more than 50,000 m2 rented space. More than 50 companies and reserach institutes are located at the park today. The buildings of the park at “Neuenheimer Feld” are private investments.



Granada – Alentia Biotech, a joint venture of Grupo Ferrer Internacional S.A. and Laboratorios Farmacéuticos Rovi S.A, has announced plans to construct a national production centre to supply the Spanish population with flu...



Lisbon – A Portuguese-American research team has discovered an association between a variant in the gene DZIP1 and Parkinson’s disease (PD). The collaboration brought André Valente from the Biocant Biotechnology Innovation Center...



Granada - Alentia Biotech, a joint venture of Spanish pharmaceuticals companies Laboratorios Farmaceuticos Rovi SA and Ferrer, will invest €92m in the construction of a flu vaccines plant in Granada. The annual production...



Madrid - Spain unveiled a grand alliance between all stakeholders in biomedicine to foster innovation in the sector. Minister of Science and Innovation, Cristina Garmendia, met the representatives of institutions, public research...

Italy, SpainSpain


Vinaros – The Italian company Transactiva failed to start a field trial of a genetically modified rice variant in southeastern Spain. Although the National Commission on Biosafety had approved the field trial, the Committee on...



Madrid/Ingelheim – Pharmaceutical company Boehringer Ingelheim has cleared the way for Spanish rival Almirall and ended a long-standing patent squabble, although the reconciliation was not exactly voluntary. Behind the scenes,...



Madrid – Spain is working to establish itself as a European hotspot for bio­energy production. The country’s Abengoa Bioenergia Nuevas Tecnologias, a subsidiary of Abengoa Bioenergy, will lead an international consortium in the...



Madrid – Agendas, working committees and associations in Europe’s biotechnology sector are not hard to find. Now the spanking new Spanish Biotech Platform (launched in May) has to show if it is more than just another extension of...



Madrid – Noscira, a Madrid-based company looking for Alzheimer treatments in marine life forms, raised a19m in a private placement of 3.8 million shares at EUR5 to existing and new investors. The main stakeholder is Zeltia S.A,...

Displaying results 11 to 20 out of 181

< Previous 11-20 Next >

© 2007-2015 BIOCOM


LentiKat’s offers an unusual investment opportunity

LentiKat’s owns, manufactures and distributes a patented immobilization into lentil-shaped Lentikats Biocatalysts. The unique lentil-like shape of the Lentikats Biocatalyst ensures unlimited diffusion of substrate(s) into any part of the matrix, while still retaining a convenient size for easy separation from the reaction medium. They find application in the Pharma & Food industry (including bio-based chemicals), Wastewater treatment as well as Biofuels. more...

Product of the week



All Events


Frankfurt am Main (DE)


Stock list

All quotes


  • BASILEA133.60 CHF4.70%
  • WILEX4.20 EUR3.45%


  • MEDIGENE8.58 EUR-4.88%
  • PAION2.51 EUR-4.56%
  • CYTOS0.63 CHF-3.08%


  • 4SC4.65 EUR257.7%
  • SYNGENTA422.00 CHF28.3%
  • SARTORIUS169.65 EUR18.6%


  • CYTOS0.63 CHF-37.6%
  • MEDIGENE8.58 EUR-33.2%
  • CO.DON2.89 EUR-8.3%


  • WILEX4.20 EUR418.5%
  • FORMYCON27.70 EUR316.5%
  • 4SC4.65 EUR315.2%


  • MOLOGEN4.92 EUR-53.7%
  • BIOFRONTERA2.30 EUR-28.6%
  • PAION2.51 EUR-22.8%

No liability assumed, Date: 25.05.2015

Current issue

All issues